The recently modified CHROMagar Acinetobacter medium was evaluated for detection of carbapenemase-producing Acinetobacter baumannii from spiked stools. A total of 45 Acinetobacter spp. isolates were tested. The CHROMagar Acinetobacter medium had a high sensitivity of 86.5% and a specificity of 75%. This medium is likely to be most useful for controlling outbreaks and in endemic situations.
Acinetobacter spp. are an important source of healthcare-associated infections. The spread of carbapenemase-producing Acinetobacter spp. is increasingly reported worldwide associated with multidrug resistance (Bonnin et al., 2013a; Poirel and Nordmann, 2006; Wareham et al., 2008) . Therefore, targeted surveillance of high-risk patients based on screening of carriers is essential to control the spread of carbapenem-resistant Acinetobacter spp. (CRAB). Resistance to carbapenems in Acinetobacter spp. may result from decreased permeability of the outer membrane, modification of penicillin-binding proteins, production of carbapenemases, and mostly from combined resistance mechanisms (Bonnin et al., 2013a; Poirel and Nordmann, 2006; Fernández-Cuenca et al., 2003) . Carbapenemases in Acinetobacter spp. belong to Ambler class A (KPC and some GES variants) (Bonnin et al., 2013b; Robledo et al., 2010) , class B (VIM, IMP, SIM, NDM) (Bonnin et al., 2012; Poirel and Nordmann, 2006) , and mostly class D (oxacillinases) (Bonnin et al., 2013a) . Five main groups of oxacillinases with carbapenemase activity have been identified in A. baumannii, i.e., the intrinsic chromosomal OXA-51-like and the acquired chromosomally and plasmid-encoded OXA-23-like, OXA-40-like, OXA-58-like, and OXA-143-like enzymes (Bonnin et al., 2013a; Higgins et al., 2009; Poirel and Nordmann, 2006) . When the bla OXA-51-like genes are expressed at a basal level, they do not confer carbapenem resistance. However, the insertion of the insertion sequence ISAba1 upstream of the bla OXA-51-like gene may lead to overexpression of this oxacillinase gene leading to carbapenem resistance (Turton et al., 2006) . Selective media developed for detection of carbapenem-resistant Enterobacteriaceae are inappropriate for detection of CRAB, since Acinetobacter spp. are intrinsically resistant to several carbapenem molecules that are contained in those selective media. CHROMagar Acinetobacter (CHROMagar, Paris, France) is a selective medium designed for rapid identification of CRAB inhibiting the growth of yeast, carbapenemsusceptible Gram negatives and Gram positives, and coloring the colonies of Acinetobacter spp. in red since it contains a chromogenic molecule (Ajao et al., 2011; Gordon and Wareham, 2009) . A new formula of this medium has been recently developed (Song et al., 2013) . As compared to the previous version of the CHROMagar Acinetobacter medium, it contains an antimicrobial selective supplement (CR102; CHROMagar) aimed to select for CRAB.
While previous studies on previous formulas of this medium included strains for which the molecular mechanisms of resistance was not determined, our aim was to evaluate the performance of this CHROMagar Acinetobacter medium using a set of precisely moleculardefined carbapenemase producers. Spiked stools were used to mimic the in vivo colonization of stools.
Forty-five Acinetobacter spp. isolates (mostly A. baumannii) were tested, including 37 acquired carbapenemase producers as follows: Ambler class A (GES-11-, GES-14-type) producers (n = 2), Ambler class B (IMP, VIM, SIM, NDM-type) producers (n = 7), Ambler class D (OXA-23-type, OXA-40-type, OXA-58-type) producers (n = 28), and 8 strains that do not produce acquired carbapenemases (n = 8), the last being either carbapenem resistant or carbapenem susceptible. OXA-23 producers are by far the most widespread carbapenemase producers in A. baumannii (Bonnin et al., 2013a) . MIC values of imipenem and meropenem (A. baumannii is naturally resistant to ertapenem) were determined by E-test and interpreted according to the CLSI guidelines updated in 2014. MIC breakpoints for imipenem and meropenem against A. baumannii were susceptibility for MICs ≤2 μg/mL, intermediate resistance 4 μg/mL, and resistance for MICs ≥8 μg/mL, as updated in CLSI (2014). The CHROMagar Acinetobacter medium was prepared as recommended by the manufacturer from dehydrated powder and liquid supplement added in the form of antimicrobial selective supplement (CR102). Bacterial suspensions of the strains with an optical density of 0.5 McFarland (inoculum of~5 × 10 7 CFU/mL) were serially diluted in water. Ten fold dilutions were made. To quantify the viable bacteria in each dilution, trypticase soy agar was inoculated concomitantly with 100 μL of suspension and incubated overnight at 37°C; the number of viable colonies was counted the following day. Spiked fecal samples were made by adding 100 μL of each dilution to 900 μL of fecal suspension that was obtained by suspending 4 g of freshly pooled feces from four healthy volunteers in 40 mL of distilled water, as previously described (Naas et al., 2011) . A fecal suspension without the addition of a bacterial strain was used as negative control. The lowest detection limit of the carbapenemase producers was determined by plating 100 μL of each dilution on CHROMagar Acinetobacter medium (CHROMagar). Viable bacteria were counted after 24 h of culture at 37°C. The sensitivity and specificity were determined using a cutoff value set at ≥1 × 10 3 CFU/mL, as previously described (Nordmann Abbreviations: IPM = imipenem; MEM = meropenem. Underlined CFU counts are considered as negative results (cutoff values set at ≥1 × 10 3 CFU/mL). a One milliliter of stools contains 100 mg of stool. et al., 2012), i.e., a limit detection value of 1 × 10 3 CFU/mL or higher was considered as lack of detection (Table 1 ). This value may correspond to a low-level carriage of multidrug-resistant bacteria in stools. Carbapenemase-producing A. baumannii were well detected from spiked stools except some OXA-58 producers (Table 1) . Lack of detection was noticeable for 2 OXA-58 producers with high-level resistance to carbapenems. The sensitivity of detection of carbapenemaseproducing A. baumannii using the CHROMagar Acinetobacter medium (86.5%) was lower than the sensitivity of detection of carbapenemresistant A. baumannii (91.7%), similarly to what was previously reported for detection of multidrug-resistant A. baumannii in an outbreak situation in intensive care unit in 2009 in the UK (sensitivity of 91.7%) (Gordon and Wareham, 2009) . This difference may be due to a lower limit of detection that has been set here at 10 3 CFU/mL. Further studies should clinically validate this cutoff value with carbapenem-resistant A. baumannii isolates. Sensitivity would have been 94.6% when just considering growth or no growth, as done in this British study (Gordon and Wareham, 2009 ). We identified specificity of the CHROMagar Acinetobacter medium of 75% that was lower than that previously reported by Gordon and Wareham (2009) (89.7%) . Our specificity result was lower since we included in "non-acquired carbapenemase-producers" 2 strains of A. baumannii with insertion of ISAba1 upstream of the naturally occurring bla OXA-51 gene. This resulted in the overexpression of this oxacillinase gene and thus decreased susceptibility to carbapenems, as previously reported (Brown et al., 2005; Turton et al., 2006) . Moran-Gilad et al. (2014) showed that CHROMagar Acinetobacter medium had a sensitivity of 100% for detection of isolates with MICs of imipenem N32 μg/mL and a specificity of 100% for isolates with MICs of imipenem b1 μg/mL (Moran-Gilad et al., 2014) . Our study shows that this rule is not applicable in all cases (Table 1) . Neither imipenem nor meropenem MIC could be strictly correlated with the detection limit of the CHROMagar Acinetobacter medium, as exemplified by the following strains, A. baumannii KOW, IMP, and CA6, which produce GES-11, IMP-1 and SHV-5, respectively. Although these strains showed similar MICs, the carbapenemase producers were specifically detected on the CHROMagar Acinetobacter medium (Table 1) .
Noticeably, this medium showed a good specificity, since no other bacteria from stools were detected on the CHROMagar Acinetobacter medium. This result correlated with that of previous studies on previous formulations of this medium. Wareham and Gordon (2011) showed that the use of the KPC supplement enabled recovery of carbapenemresistant A. baumannii, distinguishable from carbapenem-resistant Enterobacteriaceae by the color of the colonies, and Barsoumian et al. (2013) showed that the CR102 supplement prevented the growth of other bacterial species even if carbapenem resistant (Barsoumian et al., 2013) .
Overall, the studied screening medium has a good efficiency for detection of carriers of CRAB and is likely to be most useful during outbreaks or when CRAB is endemic. At least, based on this study performed with spiked stools, the CHROMagar Acinetobacter medium can detect not only Ambler class A (GES-type carbapenemase), Ambler class B, but also class Ambler D producers (in particular the most widespread OXA-23) (Mugnier et al., 2010) . The CHROMagar Acinetobacter medium is well adapted for direct inoculation of patient samples (rectal swabs, stools, skin, and nasal samples) in any clinical settings, as recently shown by Song et al. (2013) . Use of this screening medium based on detection of carbapenem resistance is of special interest since most of the carbapenem-resistant A. baumannii isolates express an acquired carbapenemase (here 36 out of 37 strains) and the carbapenem resistance trait is associated to multidrug resistance and vice versa.
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